Abstract
Background: Thiazole derivatives are known as important sulfur containing heterocycles which are present in a wide range of biologically active natural products.
Methods: A series of thiazolone derivatives were synthesized and evaluated for their soybean 15-LOX inhibitory activity. The title compounds were prepared by the reaction of 2-arylthiazol-4(5H)-ones and different aromatic aldehydes. All compounds were characterized and evaluated against soybean 15-LOX. Results: Among the synthesized thiazolone derivatives, 5-(4-methoxybenzylidene)-2-((2-methoxyphenyl) amino)thiazol-4(5H)-one (3l) was found to be the most active compound comparing with quercetin as the reference drug. Conclusion: It seems that prepared thiazolones having methoxy groups both on aryl and aminoaryl moieties can be considered for further drug discovery research.Keywords: Heterocycles, inhibitory activity, 15-LOX, synthesis, thiazolones.
Graphical Abstract
Letters in Organic Chemistry
Title:Synthesis of Thiazolone Derivatives as Novel Soybean 15-LOX Inhibitors
Volume: 14 Issue: 3
Author(s): Mohammad Mahdavi, Mina Saeedi, Hamid Nadri, Mohammad Eghtedari, Sama Gholizadeh, Roshanak Hariri and Tahmineh Akbarzadeh*
Affiliation:
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences P.O. Box: 14155-6451, Tehran,Iran
Keywords: Heterocycles, inhibitory activity, 15-LOX, synthesis, thiazolones.
Abstract: Background: Thiazole derivatives are known as important sulfur containing heterocycles which are present in a wide range of biologically active natural products.
Methods: A series of thiazolone derivatives were synthesized and evaluated for their soybean 15-LOX inhibitory activity. The title compounds were prepared by the reaction of 2-arylthiazol-4(5H)-ones and different aromatic aldehydes. All compounds were characterized and evaluated against soybean 15-LOX. Results: Among the synthesized thiazolone derivatives, 5-(4-methoxybenzylidene)-2-((2-methoxyphenyl) amino)thiazol-4(5H)-one (3l) was found to be the most active compound comparing with quercetin as the reference drug. Conclusion: It seems that prepared thiazolones having methoxy groups both on aryl and aminoaryl moieties can be considered for further drug discovery research.Export Options
About this article
Cite this article as:
Mahdavi Mohammad, Saeedi Mina, Nadri Hamid, Eghtedari Mohammad, Gholizadeh Sama, Hariri Roshanak and Akbarzadeh Tahmineh*, Synthesis of Thiazolone Derivatives as Novel Soybean 15-LOX Inhibitors, Letters in Organic Chemistry 2017; 14 (3) . https://dx.doi.org/10.2174/1570178614666170227143902
DOI https://dx.doi.org/10.2174/1570178614666170227143902 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Histone Deacetylase Inhibitors and Colorectal Cancer: what is new?
Anti-Cancer Agents in Medicinal Chemistry Weight Optimized Neural Network Using Metaheuristics for the Classification of Large Cell Carcinoma and Adenocarcinoma from Lung Imaging
Current Signal Transduction Therapy Editorial on the Occasion of the 20th Anniversary of Endocrine Metabolic Immune Disorders-Drug Targets Journal with a Kaleidoscopic Vision of Selected Publications
Endocrine, Metabolic & Immune Disorders - Drug Targets Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer
Current Medicinal Chemistry Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Current Drug Targets Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
Current Cancer Drug Targets Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Radionuclide Molecular Imaging Using Affibody Molecules
Current Pharmaceutical Biotechnology Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention
Anti-Cancer Agents in Medicinal Chemistry TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Current Pharmaceutical Design From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry Structure-Activity Relationships of Flavonoids
Current Organic Chemistry Numb Induces E-Cadherin Adhesion Dissolution, Cytoskeleton Reorganization, and Migration in Tubular Epithelial Cells Contributing to Renal Fibrosis
Current Molecular Medicine Pancreatic Neuroendocrine Tumors: Signal Pathways and Targeted Therapies
Current Molecular Medicine Immunotherapy and Radiation Therapy in Renal Cell Carcinoma
Current Drug Targets Multidrug Resistance in Cancer Chemotherapy and Xenobiotic Protection Mediated by the Half ATP-Binding Cassette Transporter ABCG2
Current Medicinal Chemistry - Anti-Cancer Agents The Effect of HCV Eradication after Direct-Acting Antiviral Agents on Hepatic Steatosis: A Prospective Observational Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection
Mini-Reviews in Medicinal Chemistry Therapy of Chronic Hepatitis C Virus Infection in HIV Co-Infected People
Current Pharmaceutical Design